Strategic Partnerships AB ANALITICA has recently collaborated with EZ Lab to develop a blockchain-based solution ensuring authenticity of COVID-19 diagnostic kits, indicating openness to co-development and security-focused partnerships that can be leveraged for joint go-to-market opportunities.

Advanced Diagnostics The company invests in its own R&D focused on molecular biology diagnostics across microbiology, virology, onco-hematology, and genetics, presenting opportunities to cross-sell enhanced nucleic acid testing technologies and in vitro diagnostic solutions to current and prospective customers.

ISO Quality Advantage With UNI EN ISO 9001 and ISO 13485 certifications, AB ANALITICA demonstrates strong quality management and regulatory compliance, making it a credible supplier for healthcare institutions seeking certified IVD products and reliable supply partners.

Distribution Reach A national sales agent network in Italy plus export distributors implies existing channels for rapid market penetration and potential to scale sales through partner-led campaigns and integrated logistics.

Diversified Portfolio Capabilities spanning breath test technology, nucleic acid diagnostics, biobanking systems, and isotope-based approaches offer multiple entry points for selling into clinical labs, research centers, and biobanking facilities, enabling cross-sell and upsell opportunities.